Hermetica Superfood Encyclopedia
The Short Answer
Lignosus rhinocerotis contains β-glucan polysaccharides, linoleic acid, terpenoids, flavonoids, and lignans that exert anti-inflammatory effects by suppressing nitric oxide production in microglial cells and modulating cytokine release. In preclinical cell-based studies, hot aqueous and n-butanol fractions inhibited LPS-induced nitric oxide production by up to 88.95% at 500 µg/mL, and sclerotium extracts elevated TNF-α and IFN-α levels in immunosuppressed models, though no human clinical trials have yet confirmed these effects.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordLignosus rhinocerotis benefits
Tiger Milk Mushroom — botanical close-up
Health Benefits
**Anti-Inflammatory Activity**
β-glucan-rich polysaccharides and an ethyl acetate fraction reduce nitric oxide (NO) production in BV2 microglial cells by 12–70% at 10–100 µg/mL, indicating suppression of neuroinflammatory signaling cascades.
**Neuroprotective Potential**
Preclinical data suggest Lignosus rhinocerotis extracts may protect neural tissue partly through microglial NO suppression and antioxidant mechanisms, with traditional use in Malaysian ethnomedicine specifically citing neurological and memory-related conditions.
**Antioxidant Capacity**
Polyphenol and flavonoid compounds in the rhizomorph (LRR) fraction confer measurable free-radical scavenging activity, with ABTS values of 86.5 ± 4 mg Trolox equivalents per gram and DPPH inhibition of 29.4 ± 1.7%, indicating moderate antioxidant potency.
**Immunomodulatory Effects**
Sclerotium water extract significantly elevated TNF-α to 997.00 ± 39.32 pg/mL and IFN-α to 880.24 ± 25.93 pg/mL compared to untreated controls in immunosuppressed animal models, suggesting upregulation of innate immune signaling.
**Fibrinolytic and Antithrombotic Properties**
A fibrinolytic enzyme isolated from L. rhinocerotis (151.61 U/mg activity; estimated molecular weight 55–60 kDa) and a protease-like enzyme (50–55 kDa) have demonstrated antiplatelet activity in human blood ex vivo, suggesting cardiovascular-relevant bioactivity.
**Respiratory and Pulmonary Support**
Polysaccharide fractions have shown inhibitory effects on lung damage in animal models with mechanisms partially attributed to attenuation of oxidative stress and inflammatory mediator release, consistent with traditional use for respiratory ailments.
**Potential Antitumor Activity**
Linoleic acid and β-glucan fractions reduced BEAS-2B (human bronchial epithelial) cell viability by approximately 30% at concentrations of 62.5–250 µg/mL in vitro, indicating cytotoxic potential against specific cell lines, though selectivity and in vivo relevance remain to be established.
Origin & History
Natural habitat
Lignosus rhinocerotis is a tropical polypore fungus native to the rainforests of Southeast Asia, particularly Malaysia, Indonesia, Thailand, and parts of southern China, where it grows as a sclerotium (underground tuber) beneath the soil surface in humid, lowland forest ecosystems. The fungus is associated with decaying organic matter and specific forest floor microclimates, making wild harvesting unpredictable and historically rare, which contributed to its high cultural and medicinal value. Controlled cultivation using mycelium propagation technology has been developed more recently in Malaysia to ensure consistent supply for research and commercial use.
“Lignosus rhinocerotis, locally known as 'Cendawan Susu Rimau' (tiger milk mushroom) in Malaysia, has been used by indigenous Orang Asli communities in the Malay Peninsula for an estimated 400 years as a remedy for a wide range of ailments including coughs, asthma, fever, breast cancer, food poisoning, and neurological conditions. The mushroom's common name derives from the folk belief that it grows from the ground where a tigress's milk fell, investing it with powerful healing symbolism and making it one of the most prized medicinal organisms in Malaysian traditional medicine. The sclerotium is the medicinally active underground portion and was traditionally prepared as a decoction by boiling sliced dried tuber in water, sometimes combined with other local herbs, and administered as a tonic for respiratory and general systemic complaints. Recognition of its potential in modern biomedicine has prompted the Malaysian government and universities to prioritize research and cultivation programs, culminating in the development of cultivated mycelium strains used in contemporary research studies.”Traditional Medicine
Scientific Research
The evidence base for Lignosus rhinocerotis consists entirely of preclinical research: in vitro cell-based assays, ex vivo human blood studies, and animal toxicology models, with no published human clinical trials available as of the current literature review. Anti-inflammatory activity has been replicated across multiple extract fractions (hot aqueous, ethyl acetate, n-butanol) in LPS-stimulated BV2 microglial and macrophage cell models, with quantified NO inhibition providing mechanistically interpretable data points. A 13-week subchronic oral toxicity study in rats using doses up to 3400 mg/kg mycelium powder demonstrated no significant adverse effects on hematological parameters (WBC, RBC) or hepatic/renal biomarkers (AST, ALT, creatinine), establishing a preliminary safety signal in rodents. The aggregate body of evidence reflects an early-stage research profile: mechanistically promising with consistent in vitro findings, but lacking dose-finding pharmacokinetic studies, bioavailability data, and randomized controlled trials in human populations necessary to establish clinical efficacy.
Preparation & Dosage
Traditional preparation
**Mycelium Powder (Oral)**
850–3400 mg/kg body weight in rat studies; no equivalent human dose established; typical commercial preparations range from 500–1000 mg/day pending clinical validation
Used in research at .
**Sclerotium Water Extract**
Traditional preparation involves boiling dried underground tuber in water; used in preclinical immunomodulation studies; concentration used in animal models approximates 500 µg/mL in cell assays.
**Hot Aqueous Extract**
Maximizes polysaccharide and β-glucan yield; 500 µg/mL inhibited LPS-induced NO by 88.95% in vitro; standardization to β-glucan content is recommended but not yet commercially mandated.
**Ethyl Acetate Fraction**
Enriched in linoleic acid, oleic acid, ethyl linoleate; active at 10–250 µg/mL in anti-inflammatory assays; not a typical consumer supplement form but used in research characterization.
**Standardized Sclerotium Extract**
Emerging commercial form; responsible manufacturers target polysaccharide content above 20% and β-glucan above 10%, though no regulatory standard exists.
**Timing and Administration**
No clinical timing data available; based on analogous medicinal mushrooms, consumption with meals may improve tolerability; morning dosing is conventional in traditional Malaysian use.
Nutritional Profile
Lignosus rhinocerotis mycelium powder contains approximately 9.0 ± 4.2% moisture, 1.9 ± 1.3% ash, 1.6 ± 2.2% crude lipid, and 8.4 ± 5.3% crude protein on a fresh weight basis. The amino acid profile is dominated by glutamate (5636 mg/100g dry weight), aspartate (2384 mg/100g), and arginine (1766 mg/100g), conferring umami flavor and potential neurotransmitter precursor relevance. Phytochemical profiling has identified 32 metabolites including flavonoids, terpenoids, lignans, and steroids, with the rhizomorph fraction (LRR) showing the highest polyphenol and flavonoid concentrations among morphological parts. The lipid fraction is predominantly unsaturated, with linoleic acid (omega-6) being the most abundant fatty acid alongside oleic acid, identified via GC-MS across 18 total constituents spanning alkane, fatty acid, benzene, phenol, and dicarboxylic acid chemical classes. Bioavailability of polysaccharides is likely influenced by extraction method, with hot aqueous extraction yielding higher β-D-glucan concentrations than cold water extraction, and no pharmacokinetic absorption data currently available for human subjects.
How It Works
Mechanism of Action
The primary anti-inflammatory mechanism of Lignosus rhinocerotis involves suppression of inducible nitric oxide synthase (iNOS)-mediated NO production in activated macrophages and BV2 microglial cells, with ethyl acetate fractions containing linoleic acid, oleic acid, and ethyl linoleate identified as key contributors to this effect at 10–500 µg/mL. β-D-glucan polysaccharides interact with pattern recognition receptors such as Dectin-1 and potentially toll-like receptors (TLRs), triggering downstream NF-κB modulation and cytokine regulation, including upregulation of TNF-α and IFN-α in immunosuppressed states. The fibrinolytic enzyme (55–60 kDa) acts through protease-like catalytic activity to degrade fibrin clots and inhibit platelet aggregation in human blood, while polyphenolic compounds including flavonoids and lignans scavenge reactive oxygen species via electron donation, reducing lipid peroxidation and protecting cellular membranes. Terpenoid and steroid metabolites among the 32 identified secondary metabolites may contribute additional bioactivity through membrane interactions and potential inhibition of pro-inflammatory arachidonic acid pathway enzymes, though specific receptor binding and gene expression targets require further elucidation.
Clinical Evidence
No human clinical trials evaluating efficacy endpoints for Lignosus rhinocerotis have been identified in the current literature. The only controlled human-derived data involves ex vivo antiplatelet assays using human blood, which demonstrated activity of aqueous sclerotium extract but did not constitute an interventional clinical study. Animal and cellular studies support biological plausibility for anti-inflammatory, immunomodulatory, and antioxidant effects, with quantified outcomes in defined model systems, but effect sizes and dose-response relationships in humans remain entirely unknown. Confidence in clinical benefit is low given the absence of translational data; the ingredient should currently be regarded as a preclinical-stage candidate requiring Phase I safety and pharmacokinetic studies before efficacy claims can be substantiated.
Safety & Interactions
In a 13-week subchronic oral toxicity study in rats, mycelium powder at doses up to 3400 mg/kg body weight produced no significant changes in white blood cell count (6.308–7.327 × 10³/µL), red blood cell count (9.173–9.464 × 10⁶/µL), liver enzymes AST (117.96–129.73 U/L) or ALT (29.24–31.93 U/L), creatine kinase, or amylase compared to controls, suggesting an acceptable short-term safety profile in rodents. However, cold water and petroleum ether extracts demonstrated cytotoxicity in BEAS-2B human bronchial epithelial cells, reducing viability by approximately 30% at 62.5–250 µg/mL, indicating that not all fractions are uniformly non-toxic and extraction method is a critical safety variable. No drug interaction data exist for Lignosus rhinocerotis in human studies; theoretical caution is warranted with anticoagulant and antiplatelet medications (e.g., warfarin, aspirin, clopidogrel) given the demonstrated ex vivo antiplatelet and fibrinolytic enzyme activity. Safety in pregnancy, lactation, pediatric populations, and individuals with autoimmune conditions or on immunosuppressive therapy has not been studied, and use in these groups cannot be recommended based on current evidence.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Lignosus rhinocerotisSusu RimauTiger Milk MushroomLRR (Lignosus rhinocerotis rhizomorph)Cendawan Susu RimauTiger Milk Mushroom (Lignosus rhinocerus Ryvarden)Fomes rhinocerotis
Frequently Asked Questions
What is tiger milk mushroom (Lignosus rhinocerotis) used for?
Tiger milk mushroom is used traditionally in Malaysian indigenous medicine for respiratory conditions such as asthma and cough, as well as for fever, liver complaints, and neurological support. Modern preclinical research has identified anti-inflammatory, antioxidant, immunomodulatory, and fibrinolytic activities driven by β-glucan polysaccharides, linoleic acid, flavonoids, and a fibrinolytic enzyme (151.61 U/mg), though human clinical trials confirming these benefits have not yet been conducted.
Is there clinical evidence supporting Lignosus rhinocerotis for human health?
As of current available literature, no human randomized controlled trials have been published for Lignosus rhinocerotis; all efficacy data derive from in vitro cell assays, ex vivo human blood studies, and animal models. While these preclinical findings are mechanistically consistent and reproducible across multiple extract fractions, they cannot be directly extrapolated to clinical outcomes in humans, and the ingredient should be regarded as a promising but early-stage research candidate.
What is the recommended dosage for tiger milk mushroom supplements?
No standardized human dosage has been established for Lignosus rhinocerotis due to the absence of clinical pharmacokinetic and dose-finding studies. Rat subchronic toxicity studies used 850–3400 mg/kg body weight without observed adverse effects, but these values cannot be directly converted to human equivalents without allometric scaling data. Commercial mycelium powder products typically suggest 500–1000 mg/day, though this range is not validated by clinical trial evidence.
Is tiger milk mushroom safe to take, and are there any side effects?
A 13-week rat study found no significant liver enzyme, kidney, or hematological abnormalities at doses up to 3400 mg/kg of mycelium powder, suggesting a reasonable short-term safety margin in rodents. However, cold water and petroleum ether extracts showed cytotoxicity in human bronchial cells at 62.5–250 µg/mL, and theoretical drug interactions with anticoagulants (e.g., warfarin) are plausible given demonstrated antiplatelet and fibrinolytic enzyme activity. Safety data in humans, pregnant women, and immunocompromised individuals are entirely absent.
How does Lignosus rhinocerotis reduce inflammation at the molecular level?
Lignosus rhinocerotis reduces inflammation primarily by suppressing inducible nitric oxide synthase (iNOS)-driven NO production in activated macrophages and BV2 microglial cells, with hot aqueous, n-butanol, and ethyl acetate fractions inhibiting LPS-induced NO by 85–89% at 250–500 µg/mL. β-D-glucan polysaccharides activate pattern recognition receptors such as Dectin-1, modulating downstream NF-κB signaling and cytokine balance, while linoleic acid, oleic acid, and polyphenolic flavonoids contribute additional antioxidant and membrane-stabilizing anti-inflammatory effects.
Does tiger milk mushroom interact with immunosuppressant medications?
Tiger milk mushroom contains immunomodulatory polysaccharides that may potentiate immune function through microglial activation and cytokine signaling. Individuals taking immunosuppressant drugs (such as corticosteroids or calcineurin inhibitors) should consult a healthcare provider before supplementing, as Lignosus rhinocerotis may counteract the intended immunosuppressive effects. The combination could potentially reduce medication efficacy or require dosage adjustments.
What is the difference between tiger milk mushroom fruiting body and mycelium extracts?
Fruiting body extracts of Lignosus rhinocerotis are generally more potent in bioactive β-glucans and polysaccharides compared to mycelium-on-grain products, which may contain significant grain filler material. Clinical studies demonstrating anti-inflammatory and neuroprotective effects have primarily used fruiting body-derived extracts standardized for polysaccharide content. For maximum efficacy, fruiting body extracts with documented β-glucan concentrations (typically 20–40%) are preferred over mycelium products.
Who benefits most from tiger milk mushroom supplementation for neurological health?
Individuals experiencing chronic neuroinflammation, age-related cognitive decline, or those seeking neuroprotective support may benefit most from Lignosus rhinocerotis, given its ability to suppress microglial nitric oxide production by up to 70% in preclinical models. People with respiratory concerns may also benefit, as tiger milk mushroom has traditional uses for lung health. However, those with acute neurological conditions or neurodegenerative diseases should seek medical guidance before use, as current evidence remains preclinical.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tiger-milk-mushroom-lignosus-rhinocerotis curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
